These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8983878)

  • 21. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.
    Sciarretta G; Furno A; Mazzoni M; Basile C; Malaguti P
    Gut; 1993 Oct; 34(10):1364-9. PubMed ID: 8244102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.
    Gorard DA; Hunt JB; Payne-James JJ; Palmer KR; Rees RG; Clark ML; Farthing MJ; Misiewicz JJ; Silk DB
    Gut; 1993 Sep; 34(9):1198-202. PubMed ID: 8406153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease.
    Okada M; Yao T; Yamamoto T; Takenaka K; Imamura K; Maeda K; Fujita K
    Hepatogastroenterology; 1990 Feb; 37(1):72-80. PubMed ID: 2179093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.
    Gassull MA; Fernández-Bañares F; Cabré E; Papo M; Giaffer MH; Sánchez-Lombraña JL; Richart C; Malchow H; González-Huix F; Esteve M;
    Gut; 2002 Aug; 51(2):164-8. PubMed ID: 12117873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
    Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.
    O'Moráin C; Segal AW; Levi AJ
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1859-62. PubMed ID: 6428577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome.
    Royall D; Jeejeebhoy KN; Baker JP; Allard JP; Habal FM; Cunnane SC; Greenberg GR
    Gut; 1994 Jun; 35(6):783-7. PubMed ID: 8020806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between serum adenosine deaminase activity and disease activity in Crohn's disease.
    Sajjadi M; Gholamrezaei A; Daryani NE
    Dig Dis Sci; 2015 Jun; 60(6):1755-60. PubMed ID: 25652144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
    Nielsen AA; Jørgensen LG; Nielsen JN; Eivindson M; Grønbaek H; Vind I; Hougaard DM; Skogstrand K; Jensen S; Munkholm P; Brandslund I; Hey H
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1121-8. PubMed ID: 16305726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assay of trace elements in the serum by the PIXE method in patients with Crohn's disease].
    Deflandre J; Weber G; Delbrouck JM; Roelandts I; Robaye G; Brassinne A
    Gastroenterol Clin Biol; 1985 Oct; 9(10):719-25. PubMed ID: 2998916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The steroid resistance of Crohn's disease.
    Mingrone G; DeGaetano A; Pugeat M; Capristo E; Greco AV; Gasbarrini G
    J Investig Med; 1999 Jul; 47(6):319-25. PubMed ID: 10431487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
    Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission following an elemental diet or prednisolone in Crohn's disease.
    Papadopoulou A; Rawashdeh MO; Brown GA; McNeish AS; Booth IW
    Acta Paediatr; 1995 Jan; 84(1):79-83. PubMed ID: 7734907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
    Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
    Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.